PD-L2 Is Constitutively Expressed in Normal and Malignant Urothelium

A.C. Dowell*, H. Munford, A. Goel, N.S. Gordon, N.D. James, K.K. Cheng, M.P. Zeegers, D.G. Ward, R.T. Bryan*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Article number626748
Number of pages7
JournalFrontiers in Oncology
Volume11
DOIs
Publication statusPublished - 25 Feb 2021

Keywords

  • bladder cancer
  • immune checkpoint inhibitors
  • PD-L1 (B7-H1 CD274)
  • PD-L2
  • programmed cell death ligand 2
  • normal urothelium

Cite this